What is the prevalence of Autoimmune Polyendocrine Syndrome?

Autoimmune Polyendocrine Syndrome (APS) is a rare disorder characterized by the malfunction of the immune system, leading to the destruction of multiple endocrine glands. APS can be classified into two types: APS type 1 (APS-1) and APS type 2 (APS-2).

APS-1 is an extremely rare autosomal recessive disorder, primarily affecting children. It is most prevalent in certain populations, such as Iranian Jews, Sardinians, and Finns. The estimated prevalence of APS-1 varies among different studies, ranging from 1 in 9,000 to 1 in 2 million individuals.

APS-2 is more common than APS-1 and typically affects adults. It is associated with other autoimmune conditions, such as type 1 diabetes, autoimmune thyroid disease, and adrenal insufficiency. The prevalence of APS-2 varies widely depending on the population studied, ranging from 1 in 1,000 to 1 in 30,000 individuals.

Due to the rarity of APS and the variability in its presentation, obtaining accurate prevalence data is challenging. However, it is generally agreed that APS is a rare disorder, with APS-1 being much rarer than APS-2. Early diagnosis and appropriate management are crucial in improving the quality of life for individuals affected by APS.